PMID- 36377016 OWN - NLM STAT- MEDLINE DCOM- 20221116 LR - 20221116 IS - 1681-7168 (Electronic) IS - 1022-386X (Linking) VI - 32 IP - 11 DP - 2022 Nov TI - Percutaneous Radiologic Gastrostomy in Patients with Stroke. PG - 1465-1469 LID - 10.29271/jcpsp.2022.11.1465 [doi] AB - OBJECTIVE: To investigate the effectiveness, safety, adverse events (AEs), and outcomes of percutaneous radiologic gastrostomy (PRG) in patients with dysphagia caused by cerebral infarction. STUDY DESIGN: An interventional study. PLACE AND DURATION OF STUDY: Department of Interventional Oncology, Dahua Hospital, and the Department of Internal medicine, Changqiao Community Health Service Center, Shanghai, China, from January 2016 and December 2019. METHODOLOGY: This study included sixty patients with cerebral infarction-induced dysphagia aged between 49-79 years. All patients were equally and randomly divided into the observation group (PRG group) and the control group (NFT group). Early and long-term results of PRG and nasal feeding tube (NFT) treatment were assessed. RESULTS: No significant differences in serum albumin, prealbumin, haemoglobin, and circumference of triceps (p>0.05) were observed between the two groups before treatment. After treatment, both serum albumin, prealbumin, haemoglobin, and the circumference of the triceps increased in the PRG group compared with the NFT group (p<0.05), indicating better nutrition status. The adverse events (AEs) rate of the PRG group (3.33%, 1/30) was significantly lower than the NFT group (30%, 9/30, p=0.005). The comfort level of the PRG group (93.33%, 28/30) was significantly higher than the NFT group (53.33%, 16/30, p<0.001). CONCLUSION: Percutaneous radiologic gastrostomy can improve the nutritional status of patients with dysphagia caused by cerebral infarction. It can reduce the incidence of AE and improve the comfort level. KEY WORDS: Percutaneous Gastroscopy, Gastrostomy, Dysphagia, Nutrition status, Complications. FAU - Yuan, Tianwen AU - Yuan T AD - Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, China. FAU - He, Yang AU - He Y AD - Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, China. FAU - Zhu, Zhixing AU - Zhu Z AD - Department of Internal Medicine, Changqiao Community Health Service Center, Xuhui District, Shanghai, China. FAU - Yang, Qi AU - Yang Q AD - Department of Internal Medicine, Changqiao Community Health Service Center, Xuhui District, Shanghai, China. FAU - Kong, Peng AU - Kong P AD - Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, China. FAU - Wang, Saibo AU - Wang S AD - Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, China. FAU - Zhou, Xing AU - Zhou X AD - Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, China. FAU - Cao, Jun AU - Cao J AD - Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, China. LA - eng PT - Journal Article PT - Randomized Controlled Trial PL - Pakistan TA - J Coll Physicians Surg Pak JT - Journal of the College of Physicians and Surgeons--Pakistan : JCPSP JID - 9606447 RN - 0 (Prealbumin) SB - IM MH - Humans MH - Middle Aged MH - Aged MH - Gastrostomy/adverse effects/methods MH - Prealbumin MH - *Deglutition Disorders/etiology MH - Retrospective Studies MH - China MH - *Stroke/complications MH - Cerebral Infarction EDAT- 2022/11/16 06:00 MHDA- 2022/11/18 06:00 CRDT- 2022/11/15 00:21 PHST- 2021/08/22 00:00 [received] PHST- 2022/03/09 00:00 [accepted] PHST- 2022/11/15 00:21 [entrez] PHST- 2022/11/16 06:00 [pubmed] PHST- 2022/11/18 06:00 [medline] AID - 040579197 [pii] AID - 10.29271/jcpsp.2022.11.1465 [doi] PST - ppublish SO - J Coll Physicians Surg Pak. 2022 Nov;32(11):1465-1469. doi: 10.29271/jcpsp.2022.11.1465.